Literature DB >> 5939308

Studies on powdered preparation. XVII. Dissolution rate of sulfonamides by rotating disk method.

H Nogami, T Nagai, A Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5939308     DOI： 10.1248/cpb.14.329

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  7 in total

1.  Program for evaluating drug dissolution kinetics in preformulation.

Authors:  M Nicklasson; A B Magnusson
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

2.  Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples.

Authors:  Ganesh Shete; Vibha Puri; Lokesh Kumar; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

3.  Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery.

Authors:  D L French; J W Mauger
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

4.  Quantitative relationship between solubility, initial dissolution rate and heat of solution of chiral drugs.

Authors:  E Yonemochi; Y Yoshihashi; K Terada
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

5.  The use of d-limonene preparation as a dissolving agent of gallstones.

Authors:  H Igimi; T Hisatsugu; M Nishimura
Journal:  Am J Dig Dis       Date:  1976-11

6.  Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy.

Authors:  Marcin Skotnicki; Barbara Jadach; Agnieszka Skotnicka; Bartłomiej Milanowski; Lidia Tajber; Marek Pyda; Jacek Kujawski
Journal:  Pharmaceutics       Date:  2021-01-18       Impact factor: 6.321

7.  Studies on the Vitrified and Cryomilled Bosentan.

Authors:  Aldona Minecka; Krzysztof Chmiel; Karolina Jurkiewicz; Barbara Hachuła; Rafał Łunio; Daniel Żakowiecki; Kinga Hyla; Bartłomiej Milanowski; Kajetan Koperwas; Kamil Kamiński; Marian Paluch; Ewa Kamińska
Journal:  Mol Pharm       Date:  2021-12-01       Impact factor: 4.939
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.